Why the study?
The impact of hyperuricemia on the prognosis of patients with heart failure with preserved ejection fraction has not been fully understood.
Does hyperuricemia increase the risk of heart failure readmission in hospitalized patients with HFpEF?
Does hyperuricemia increase the risk of heart failure readmission in hospitalized patients with HFpEF?
Hyperuricemia is a common comorbidity in HFpEF and is significantly associated with an increased risk of heart failure readmission.
May flag higher HF readmission risk in HFpEF; hypothesis-generating and requires prospective trials before practice change.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: